Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -112.76 M

Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities is USD -112.76 M for the year ending March 31, 2024, a -169.86% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -41.78 M, a -5.26% change year over year.
Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD -39.69 M, a -44.32% change year over year.
Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -27.51 M, a 20.34% change year over year.
Fukuda Denshi Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -34.53 M, a -28.29% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years